Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

aTYR PHARMA (ATYR) Assets Average (2019 - 2025)

aTYR PHARMA's Assets Average history spans 7 years, with the latest figure at $99.8 million for Q4 2025.

  • For Q4 2025, Assets Average rose 5.95% year-over-year to $99.8 million; the TTM value through Dec 2025 reached $99.8 million, up 5.95%, while the annual FY2025 figure was $94.9 million, 12.71% down from the prior year.
  • Assets Average reached $99.8 million in Q4 2025 per ATYR's latest filing, down from $104.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $134.8 million in Q2 2023 to a low of $46.9 million in Q1 2021.
  • Average Assets Average over 5 years is $101.5 million, with a median of $100.1 million recorded in 2022.
  • Peak YoY movement for Assets Average: soared 197.97% in 2021, then dropped 23.37% in 2024.
  • A 5-year view of Assets Average shows it stood at $119.7 million in 2021, then decreased by 19.88% to $95.9 million in 2022, then rose by 28.09% to $122.9 million in 2023, then decreased by 23.31% to $94.2 million in 2024, then grew by 5.95% to $99.8 million in 2025.
  • Per Business Quant, the three most recent readings for ATYR's Assets Average are $99.8 million (Q4 2025), $104.1 million (Q3 2025), and $99.4 million (Q2 2025).